PRESS RELEASE published on 02/19/2025 at 08:28, 11 months 10 days ago Inside Information / Other news releases Medincell announces successful c.€43 million Global Offering, strengthening funding for expanding BEPO® technology into new molecules and indications, integrating complementary technologies, improving shareholder structure, and enhancing financial flexibility Pharmaceutical Financial Flexibility Medincell Global Offering BEPO® Technology
BRIEF published on 02/18/2025 at 18:57, 11 months 11 days ago Medincell launches a Global Offer of 10% of its capital Profitability Partnerships Medincell Global Offer BEPO Technology
PRESS RELEASE published on 02/18/2025 at 18:52, 11 months 11 days ago Inside Information / Other news releases Medincell launches a Global Offering to expand its BEPO technology reach into new molecules and indications. Funds raised will strengthen licensing opportunities and improve shareholder structure Shareholder Structure Licensing Opportunities Medincell Global Offering BEPO Technology
BRIEF published on 02/06/2025 at 19:35, 11 months 23 days ago EIB Supports Medincell by Waiving Financial Covenants Loan Agreement Credit Facility Medincell Financial Covenants EIB
PRESS RELEASE published on 02/06/2025 at 19:30, 11 months 23 days ago Inside Information / Other news releases The EIB permanently waives two financial covenants in Medincell's loan agreement, showing confidence. €40M credit facility structure and key details explained Loan Agreement Credit Facility Medincell Financial Covenants EIB
BRIEF published on 01/29/2025 at 15:47, 1 year ago UZEDY® Achieves $117M in Sales in 2024 Teva Pharmaceuticals 2025 Projections UZEDY® Sales Medincell Partnership Olanzapine Injectable
PRESS RELEASE published on 01/29/2025 at 15:42, 1 year ago Inside Information / Other news releases UZEDY® sales reach $117M in 2024, surpassing Teva's expectations. Medincell poised for $160M in 2025 with Olanzapine Long-Acting Injectable near launch. Key partnership and financial insights Sales Partnership Medincell Teva Pharmaceuticals UZEDY®
BRIEF published on 12/12/2024 at 21:35, 1 year 1 month ago Medincell Joins Euronext SBF 120 Index Market Capitalization Medincell CAC 40 Euronext SBF 120 Financial Visibility
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 1 month ago Inside Information / Other news releases Medincell joins Euronext SBF 120 & CAC Mid 60 indices, enhancing visibility and investor appeal. Market capitalization-based indices by Euronext. Effective inclusion from Dec 20 Market Capitalization Medincell Index Inclusion Euronext SBF 120 CAC Mid 60
BRIEF published on 11/28/2024 at 18:45, 1 year 2 months ago Medincell Announces Video Conference for Half-Year Results Half-year Results Schizophrenia Medincell Videoconference BEPO Technology
Published on 01/30/2026 at 02:15, 45 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 3 hours ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 4 hours ago PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 8 hours 15 minutes ago Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 9 hours ago PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/30/2026 at 00:07, 2 hours 53 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 5 hours 58 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 5 hours 59 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/29/2026 at 20:59, 6 hours 1 minute ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 01/29/2026 at 20:57, 6 hours 3 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 01/29/2026 at 18:00, 9 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 9 hours 15 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 9 hours 15 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 10:07, 16 hours 53 minutes ago Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech
